This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Zhu, J., Quyyumi, A. A., Norman, J. E., Csako, G., Waclawiw, M. A., Shearer, G. M., & Epstein, S. E. (2000) Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels, Am. J. Cardiol., 85, 140–146.
Marshall, B. J. (1989) History of the discovery of Campylobacter pylori, in M. J. Balser (Ed.) Campylobacter pylori in gastritis and peptic ulcer disease (pp. 7–23), New York: Igaku Shoin.
Hazell, S. L., Lee, A., Brady, L., & Hennessy, W. (1986) Campylobacter pyloridis and gastritis: association with intracellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium, J. Infect. Dis., 153, 658–663.
Paull, G., & Yardley, J. H. (1989) Pathology of pylori-associated gastric and esophageal lesions, in M. J. Blaser (Ed.) Campylobacter pylori in gastritis and peptic ulcer disease (pp. 73–98), New York: Igaku Shoin.
Blaser, M. J. (2000) Helicobacter pylori and related organisms, in G. L. Mandell, J. E. Bennett, & R. Dolin (Eds.) Principles and practice of infectious diseases (5th ed., Vol. 2, pp. 2285–2293), Philadelphia: Churchill Livingstone.
Taylor, D. N., & Blaser, M. J. (1991) The epidemiology of Helicobacter pylori infections, Epidemiol. Rev., 13, 42–59.
Dooley, C. P., Fitzgibbons, P. L., Cohen, H., Bauer, M., Appleman, M. D., Perez-Perez, G. I., & Blaser, M. J. (1989) Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic person, N. Engl. J. Med., 321, 1562–1566.
Perez-Perez, G. I., Olivares, A. Z., Cover, T. L., & Blaser, M. J. (1992) Characteristics of Helicobacter pylori variants selected for urease deficiency, Infect. Immun., 60, 3658–3663.
Perez-Perez, G. I., Shepherd, V. L., Morrow, J. D., & Blaser, M. J. (1995) Activation of human THP-I cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide, Infect. Immun., 63, 1183–1187.
Sharma, S. A., Tummuru, M. K. R., Miller, G. G., & Blaser, M. J. (1995) Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro, Infect. Immun., 63, 1681–1687.
Mai, U. E., Perez-Perez, G. I., Allen, J. B., Wahl, S. M., Blaser, M. I., & Smith, P. D. (1992) Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leucocytes and are present in gastric mucosa, J. Exp. Med., 175, 517–525.
Cover, T. L. (1996) The vacuolating cytotoxin of Helicobacter pylori, Mol. Microbiol, 20, 241–246.
Covacci, A., Censini, S., Bugnoli, M., Petracca, R., Burroni, D., Macchia, G., Massone, A., Papini, E., Xiang, Z., & Figura, N. (1993) Molecular characterization of the 128kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer, Proc. Natl. Acad. Sci. USA, 90, 5791–5795.
Dunn, B. E., Cohen, H., & Blaser, M. J. (1997) Helicobacter pylori, Clin. Microbiol. Rev., 10, 720–741.
Kosunen, T. U., Seppala, K., Sarna, S., & Sipponen, P. (1992) Diagnostic value of decreased IgG, IgA and IgM antibody titers aftereradication of Helicobacter pylori, Lancet, 339, 893–895.
Marshall, B. J., & Surveyor, I. (1988) Carbon-14 urea breath test for the diagnosis of Campylobacter pylori-associated gastritis, J. Nucl. Med., 29, 11–16.
Danesh, J., Collins, R., & Peto, R. (1997) Chronic infections and coronary heart disease: is there a link? Lancet, 350, 430–436.
Ossei-Gerning, N., Moayyedi, P., Smith, S., Braunholtz, D., Wilson, J. I., Axon, A. T., & Grant, P. J. (1997) Helicobacter pylori infection is related to atheroma in patients undergoing angiography, Cardiovasc. Res., 35, 120–124.
de Luis, D. A., Lahera, M., Canton, R., Boixeda, D., San Roman, A. L., Aller, R., & de La Calle, H. (1998) Association of Helicobacter pylori infection with cardio-vascular and cerebrovascular disease in diabetic patients, Diabetes Care, 21, 1129–1132.
Markus, H. S., & Mendall, M. A. (1998) Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma, J. Neurol. Neurosurg. Psychiatry, 64, 104–107.
Danesh, J., Youngman, L., Clark, S., Parish, S., Peto, R., & Collins, R. (1999) Helicobacter pylori infection and early onset myocardial infarction: case control and sibling pairs study, BMJ, 319, 1157–1162.
Wald, N. J., Law, M. R., Morris, J. K., & Bagnall, A. M. (1997) Helicobacter pylori and mortality from ischaemic heart disease: negative result from a large prospective study, BMJ, 315, 1199–1201.
Ossewaarde, J. M., Feskens, E. J., De Vries, A., Vallinga, C. E., & Kromhout, D. (1998) Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom free elderly men, but Helicobacter pylori and cytomegalovirus are not, Epidemiol. Infect., 120, 93–99.
Folsom, A. R., Neito, F. J., Sorlie, P., Chambless, L. E., & Graham, D. Y. (1998) Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis risk in communities (ARIC) study investigators, Circulation, 98, 845–850.
Khurshid, A., Fenske, T., Bajwa, T., Bourgevis, K., & Vakil, N. (1998) A prospective controlled study of Helicobacter pylori seroprevalence in coronary artery disease, Am. J. Gastroenterol., 93, 717–720.
Danesh, J. (1999) Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus; meta-analyses of prospective studies, Am. Heart J., 138, S434–S437.
Gunn, M., Stephens, J. C., Thompson, J. R., Rathbone, B. J., & Samani, N. K. (2000) Significant association of cag A positive Helicobacter pylori strains with risk of premature myocardial infacrtion, Heart, 84, 267–271.
Koenig, W., Rothenbacher, P., Hoffmeister, A., Miller, M., Bode, G., Adler, G., Hombach, V., Marz, W., Pepys, M. B., & Brenner, H. (1999) Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin associated protein A positive strains and absence of a systemic inflammatory response, Circulation, 100, 2326–2331.
Murrary, L. J., Bamford, K. B., Kee, F., McMaster, D., Cambien, F., Dallongeville, J., & Evans, A. (2000) Infections with virulent strains of Helicobacter pylori is not associated withischemia heart disease: evidence from a population-based case-control study of myocardial infarction, Atherosclerosis, 149, 379–385.
Whincup, P. H., Mendall, M. A., Perry, I. J., Strachan, D. P., & Walker, M. (1996) Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men, Heart, 75, 568–672.
Aromaa, A., Knekt, P., Reunanen, A., Rautelin, H. I., & Kosunen, T. U. (1996) Helicobacter infection and the risk ofmyocardial infarction, Gut, 39 (Suppl. 2), A1.
Strachan, D. P., Mendall, M. A., Carrington, D., Rutland, B. K., Yarnell, J. W., Sweetnam, P. M., & Elwood, P. C. (1998) Relations of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly prospective heart disease study, Circulation, 98, 1286–1290.
Regnstrom, J., Jovinge, S., Bavenholm, P., Ericsson, C. G., De Faire, U., Hamsten, A., Hellenius, M. L., Nilsson, J., & Tornvall, P. (1998) Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease, J. Intern. Med., 243, 109–113.
Danesh, J., Wong, Y., Ward, M., & Muri, J. (1999) Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease, Heart, 81, 245–247.
Ridker, P. M., Hennekens, C. H., Buring, J. E., Kundsin, R., & Shih, J. (1999) Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus and cytomegalovirus and the risk of cardiovascular disease in women, Ann. Intern. Med., 131, 573–577.
Roivainen, M., Viik-Kajander, M., Palosuo, T., Toivainen, P., Leinonen, M., Saikku, P., Tenkanen, L., Manninen, V., Hovi, T., & Manttari, M. (2000) Infections, inflammation, and the risk of coronary heart disease, Circulation, 101, 252–257.
Whincup, P., Danesh, J., Walker, M., Lennon, L., Thomson, A., Appleby, P., Hawkey, C., & Atherton, J. (2000) Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle aged men, Circulation, 101, 1647–1652.
Choussat, R., Montalescot, G., Collet, J. P., Jardel, C., Ankri, A., Fillet, A. M., Thomas, D., Raymond, J., Bastard, J. P., Drobinski, G., Orfila, J., Agut, H., & Thomas, D. (2000) Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and oneyear prognosis of patients with unstable angina pectoris or non-Q wave acute myocardial infarction, Am. J. Cardiol., 86, 379–384.
Mayr, M., Kiechl, S., Willeit, J., Wick, G., & Xu, Q. (2000) Infection, immunity and atherosclerosis. Association of antibodies to Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus with immune reactions to heat shock protein 60 and carotid or femoral atherosclerosis, Circulation, 102, 833–839.
Zhu, J., Nieto, J., Horne, B. D., Anderson, J. L., Muhlestein, J. B., & Epstein, S. E. (2001) Prospective study of pathogen burden and risk of myocardial infarction or death, Circulation, 103, 45–51.
Rupprecht, H. J., Blankenberg, S., Bickel, C., Rippin, G., Hafher, G., Prellwitz, W., Schlumberger, W., & Meyer, J. (2001) Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease, Circulation, 104, 25–31.
Stone, A. F., Risley, P., Markus, H. S., Butland, B. K., Strachan, D. P., Elwood, P. C., & Mendall, M. A. (2001) Ischaemic heart disease and CagA strains of Helicobacter pylori in the Caerphilly heart disease study, Heart, 86, 506–509.
Ridker, P. M., Danesh, J., Youngman, L., Collins, R., Stampfer, M. J., Peto, R., & Hennekens, C. H. (2001) A prospective study of Helicobacter pylori seropositivity and the risk for futuremyocardial infarction among socioeconomically similar US men, Ann. Intern. Med., 135, 184–188.
Zhu, J., Quyyumi, A. A., Muhlestein, J. B., Nieto, F. J., Zalles-Ganley, A., Anderson, J. L., & Epstein, S. E. (2002) Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death, Am. J.Cardiol., 89, 155–158.
Blasi, F., Denti, F., Erba, M., Cosentini, R., Raccanelli, R., Rinaldi, A., Fagetti, L., Esposito, G., Ruberti, U., & Allegra, L. (1996) Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms, J. Clin. Microbiol, 34, 2766–2769.
Danesh, J., Koreth, J., Youngman, L., Collins, R., Arnold, J. R., Balarajan, Y., McGee, J., & Roskell, D. (1999) Is Helicobacter pylori a factor in coronary atherosclerosis? J. Clin. Microbiol., 37, 1651.
Malnick, S. D., Goland, S., Kaftoury, A., Schwarz, H., Pasik, S., Mashiach, A., & Sthoeger, Z. (1999) Evaluation of carotid arterial plaques after endarterectomy for Helicobacter pylori infection, Am. J. Cardiol., 83, 1586–1587.
Farsak, B., Yildirir, A., Akyon, Y., Pinar, A., Oc, M., Boke, E., Kes, S., & Tokgozoglu, L. (2000) Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR, J. Clin. Microbiol., 38, 4408–4411.
Rassu, M., Cazzavillan, S., Scagnelli, M., Peron, A., Bevilacqua, P. A., Facco, M., Bertoloni, G., Lauro, F. M., Zambello, R., & Bonoldi, E. (2001) Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions, Atherosclerosis, 158, 73–77.
Ameriso, S. F., Fridman, E. A., Leiguarda, R. C., & Sevlever, G. E. (2001) Detection of Helicobacter pylori in human carotid atherosclerotic plaques, Stroke, 32, 385–391.
Radke, P. W., Merkelbach-Bruse, S., Messmer, B. J., vom Dahl, J., Dorge, H., Naami, A., Vogel, G., Handt, S., & Hanrath, P. (2001) Infectious agents in coronary lesions obtained by endatherectomy: pattern of distribution, coinfection, and clinical findings, Coron. Artery Dis., 12, 1–6.
Montemurro, P., Barbuti, G., Dundon, W. G., Del Giudice, G., Rappuoli, R., Colucci, M., De Rinaldis, P., Montecucco, C., Semeraro, N., & Papini, E. (2001) Helicobacter pylori neutrophil activating protein stimulates tissue factor and plasminogenactivator inhibition-2 production by human blood mononuclear cells, J. Infect. Dis., 183, 1055–1062.
Xu, Q., Kiechl, S., Mayr, M., Metzler, B., Egger, G., Wick, G., Oberhollenzer, F., & Willeit, J. (1999) Association of serum antibodies to mycobacteria heat shock protein 65 with carotid atherosclerosis: clinical significance found determined in a follow-up study, Circulation, 100, 1169–1174.
Rothenbacher, D., Hoffmeister, A., Bode, G., Miller, M., Koenig, W., & Brenner, H. (2001) Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids, Atherosclerosis, 156, 193–199.
Birnie, D. H., Holme, E. R., McKay, I. C., Hood, S., McColl, K. E., & Hillis, W S. (1998) Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk, Eur. Heart J., 19, 387–394.
Galante, A., Pietroiusti, A., Carta, S., Franceschelli, L., Piccolo, P., Mastino, A., Fontana, C., Grelli, S., Bergamaschi, A., Magrini, A., & Favalli, C. (2000) Infection with Helicobacter pylori and leucocyte response in patients with myocardial infarction, Eur. J. Clin. Microbiol. Infect. Dis., 19, 298–300.
McDonagh, T. A., Woodward, M., Morrison, C. E., McMurray, J. J., Tunstall-Pedoe, H., Lowe, G. D., McColl, K. E., & Dargie, H. J. (1997) Helicobacter pylori infection and coronary heart disease in the North Glascow MONICA population, Eur. Heart J., 18, 1257–1260.
Murray, L. J., Bamford, K. B., O’Reilly, D. P. J., McCrum, E. E., & Evans, A. E. (1995) Helicobacter pylori infections: relations with cardiovascular risk factors, ischaemic heart disease and social class, Br. Heart J., 74, 497–501.
Regnstrom, J., Jovinge, S., Bavenholm, P., Ericsson, C. G., De Faire, U., Hamsten, A., Hellenius, M. L., Nilsson, J. & Tornvall, P. (1998) Helicobacter pylori seropositivity is not associated with inflammatory parameters,lipid concentrations and degree of coronary artery disease, J. Intern. Med., 243, 109–113.
Elizalde, J. I., Gomez, J., Panes, J., Lozano, M., Casadevall, M., Ramirez, J., Pizcueta, P., Marco, F., Rojas, F. D., & Granger, D. N. (1997) Platelet activation in mice and human Helicobacter pylori infection, J. Clin. Invest., 100, 996–1005.
Zito, F., Di Castelnuovo, A., D’Orazio, A., Negrini, R., De Lucia, D., Donati, M. B., & Iacoviello, L. (1999) Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control, Thromb. Haemost., 82, 14–18.
Torgano, G., Cosentini, R., Mandelli, C., Perondi, R., Blasi, F., Bertinieri, G., Tien, T. V, Ceriani, G., Tarsia, P., Arosio, C., & Ranzi, M. L. (1999) Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma levels in patients with ischaemic heart disease, Circulation, 99, 1555–1559.
Carter, A. M., Moayyedi, P., Catto, A., Heppell, R. M., Axon, A. T, & Grant, P. J. (1996) The influence of Helicobacter pylori status on circulating levels of coagulation factors fibrinogen, von Willebrand factor, Factor VII, and Factor VIII, Helicobacter, 1, 65–69.
Welch, G. N., & Loscalzo, J. (1998) Homocysteine and atherothrombosis, N. Engl. J. Med., 338, 1042–1049.
Markle, H. V. (1997) Coronary artery disease associated with Helicobacter pylori infection is at least partially due to inadequate folate status, Medical Hypothesis, 49, 289–292.
Cenerelli, S., Bonazzi, P., Galeazzi, R., Testa, I., Bonfili, A. R., Sirolla, C., Giunta, S., Galeazzi, L., Fumelli, D., & Testa, R. (2002) Helicobacter pylori masks differences in homocysteine plasma levels between controls and Type 2 diabetes patients, Eur. J. Clin. Invest., 32, 158–162.
Aydin, A., Vardar, R., Evrengu, I. H., Ungan, M., Yilmaz, M., & Payzin, S. (2001) Does Helicobacter pylori infection have a role in coronary artery disease? Turkish J. Gastro., 12, 287–293.
Ekesbo, R, Nilsson, P. M, Lindholm, L. H., Persson, K., & Wadstrom, T. (2000) Combined seropositivity for H. pylori and C. pneumoniae in associated with age, obesity and social factors, J. Cardiovasc. Risk, 7, 191–195.
Niemela, S., Karttunen, T., Karhonen, T., Laara, E., Karttunen, R., Ikaheimo, M., & Kesaniemi, Y. A. (1996) Could Helicobacter pylori infection increase the risk of coronary heart disease by modifyingserum lipid concentrations? Heart, 75, 573–575.
Marchetti, M., Arico, B., Burroni, D., Figura, N., Rappuoli, R., & Ghiara, P. (1995) Development of a mouse model of Helicobacter pylori infection that mimics human disease, Science, 267, 1655–1658.
Eaton, K. A., Morgan, D. R., & Krakowka, S. (1989) Campylobacter pylori virulence factors in gnotobiotic piglet, Infect. Immun., 57, 1119–1125.
Tsuda, M., Karita, M., Morshed, M. G., Okita, K., & Nakazawa, T. (1994) A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach, Infect. Immun., 62, 3586–3589.
Hazell, S. L., Eichberg, J. W., Lee, D. R., Alpert, L., Evans, D. G. Evans, D. J., Jr., & Graham, D. Y. (1992) Selection of the chimpanzee over the baboon as a model for Helicobacter pylori infection, Gastroenterology, 103, 848–854.
Wirith, H. P., Beins, M. H, Yang, M, Tham, K. T., & Blaser, M. J. (1998) Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains, Infect. Immun., 66, 4856–4866.
Mach, F., Sukhova, G. F., Michetti, M., Libby, P., & Michetti, P. (2002) Influence of Helicobacter pylori infection during atherogenesis in vivo in mice, Circ. Res., 90, el (circresaha.org).
Blessing, E., Campbell, L. A., Rosefeld, M. E., Choug, L. N., & Kuo, C. C. (2001) Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice, Atherosclerosis, 158, 13–17.
Kowalski, M., Konturek, P. C., Pieniazek, P., Karczewska, E., Kluczka, A., Grove, R., Kranig, W, Nasseri, R., Thale, J., Hahn, E. G., & Konturek, S. J. (2001) Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty, Dig. Liver Dis., 33, 222–229.
Stone, A. F. M., Mendall, M. A., Kaski, J., Edger, T. M., Gupta, S., Polonieck, J., Camm, A. J., & Northfield, T. C. (2001) The South Thames trail of antibiotics in myocardial infarction and unstable angina (STAMINA trail), Eur. Heart J., 22 (Abstract suppl), 643 [Abstract p3516].
Nicholls, A. C., & Thomas, M. (1977) Coxsackie virus infection in acute myocardial infarction, Lancet, 1, 883–884.
Wood, S. F., Rogen, A. S., Bell, E. J., & Grist, N. R. (1978) Role of coxsackie B virus in myocardial infarction, Br. Heart J., 40, 523–525.
Griffiths, P. D., Hannington, G., & Booth, J. C. (1980) Coxsackie B virus infections and myocardial infarction: results from a prospective epidemiologically controlled study, Lancet, 1, 1387–1389.
Pönkä, A., Jalanko, H., Pönkä, T., & Stenvik, M. (1981) Viral and mycoplasmal antibodies in patients with myocardial infarction, Ann. Clin. Res., 13, 429–432.
Lau, R. C. (1982) Coxsackie B virus infection in acute myocardial infarction and adult heart disease, Med. J. Aust., 2, 520–522.
O’Neill, D., McArthur, J. D., Kennedy, J. A., & Clements, G. (1983) Coxsackie B virus infection in coronary care unit patients, J. Clin. Pathol., 36, 658–661.
Nikoskelainen, J., Kalliomäki, J. L., Lapin Leimu, K., Stenvik, M., & Halonen, P. E. (1983) Coxsackie B virus antibodies in myocardial infarction, Acta Med. Scand., 214, 29–32.
Matilla, K. J. (1987) Viral and bacterial infections in patients with acute myocardial infarction, J. Intern. Med., 225, 293–296.
Miklozek, C. L., Crumpacker, C. S., Royal, H. D., Come, P. C., Sullivan, J. L., & Abelmann, W. H. (1988) Myocarditis presenting as acute myocardial infarction, Am. Heart J., 115, 768–776.
Collins, S. D. (1932) Excess mortality from causes other than influenza and pneumonia during influenza epidemics, Public Health Rep., 47, 2159–2180.
Bainton, D., Jones, G. R., & Hole, D. (1978) Influenza and ischaemic heart disease: a possible trigger for acute myocardial infarction? Int. J. Epidemiol, 7, 231–239.
Zheng, Z. J., Mittleman, M. A., Tofler, G. H., Pomeroy, C., Dampier, C., Wides, B., & Muller, J. E. (1998) Infections prior to acute MI onset, J. Am. Coll. Cardiol, 31(Suppl. A), 132A.
Abinader, E. G., Sharif, D. S., & Omary, M. (1993) Inferior wall infarction preceded by acute exudative pharyngitis in young males, Israel J. Med. Sci., 29,764–769.
Spodick, D. H., Flessas, A. P., & Johnson, M. M. (1984) Association of acute respiratory symptoms with onset of acute myocardial infarction: a prospective investigation of 150 consecutive patients and matched control patients, Am. J. Cardiol., 53, 481–482.
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) The efficiency of influenza vaccine in elderly persons: a meta-analysis and review of the literature, Ann. Intern. Med., 123, 518–527.
Naghavi, M., & Casscells, W. (2000) Association of influenza vaccination and reduced risk of recurrent myocardial infarction, Circulation, 102, 3039–3045.
Lavallee, P., Perchaud, V, Gautier-Bertrand, M., Grabli, D., & Amarenco, P. (2002) Association between influenza vaccination and reduced risk of brain infarction, Stroke, 33, 513–518.
Falsey, A. R., Walsh, E. E., Francis, C. W., Looney, R. J., Kolassa, J. E., Hall, W. J., & Abraham, G. N. (2001) Response of C-reactive protein and serum amyloid A to influenza A infection in older adults, J. Infect. Dis., 183, 995–999.
Feinstone, S. M., & Gust, I. A. (2000) Hepatitis A virus, in G. L. Mandell, J. E. Bennett, & R., Dolin (Eds.) Principles and practice of infectious diseases (5th edn, Vol. 2, pp. 1920–1940), Philadelphia: Churchill Livingstone.
Zhu, J., Quyyumi, A. A., Norman, J. E., Costello, R., Csako, G., & Epstein, S. E. (2000) The possible role of Hepatitis A virus in the pathogenesis of atherosclerosis, J. Infect. Dis., 182, 1583–1587.
Dezube, B. J., Pardee, A. B., Chapman, B., Beckett, L. A., Korvick, J. A., Novick, W. J., Chiurco, J., Kasdan, P., Ahlers, C. M., Ects, L. T., Crumpacker, C. S., & the NIAD AIDS Clinical Trials Group (1993) Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS, J. Acquir Immune Defic Syndr., 6, 787–794.
Krishnaswamy, G., Chi, D. S., Kelley, J. L., Sarubbi, E, Smith, J. K., & Peiris, A. (2000) The cardiovascular and metabolic complications of HIV infection, Cardiol. Rev., 8, 260–268.
Henry, K., Melroe, H., Huebsch, J., Hermundson, J., Levine, C., Swensen, L., & Daley, J. (1998) Severe premature coronary artery disease with protease inhibitors, Lancet, 351, 1328.
Hadigan, C., Meigs, J., Corcoran, C., Rietschel, P., Piecuch, S., Basgoz, N., Davis, B., Sax, P., Stnaley, T., Wilson, P. W. E, D’Agostino, R. B., & Grinspoon, S. (2001) Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy, Clin. Infect. Dis., 32, 130–139.
David, M. H., Hornung, R., & Fichtenbaum, C. J. (2002) Ischemic cardiovascular disease in persons with human immunodeficiency virus infection, Clin. Infect. Dis., 34, 98–102.
Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999) Diagnosis, prediction, and natural course of HIV-1 protease inhibitor associated lipodystropy, hyperlipidemia, and diabetes mellitus: a cohort study, Lancet, 353, 2093–2099.
Hadigan, C., Corcoran, C., Stanley, T, Piecuch, S., Klibanski, A., & Grinspoon, S. (2000) Fasting hyperinsulinemia in HIV-infected men: relationship to body composition, gonadol function and protease-inhibitor use, J. Clin. Endocrin. Metab., 85, 35–41.
Saint-Marc, T., Partisani, M., Poizot-Martin, I., Bruno, F., Rouviere, O., Lang, J. M., Gastaut, J. A., & Touraine, J. L. (1999) A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy, AIDS, 13, 1659–1667.
Walker, U. A., Bickel, M, Lütke, Volksbeck, S. I, Ketelsen, U. P., Schöfer, H., Setzer, B., Venhoff, N., Rickerts, V, & Staszewski, S. (2002) Evidence of nucleoside analogue reverse transcriptase inhibitor-associated genetic and structural defects of mitochondria in adipose tissue of HIV infected patients, J. Acquir. Immune Defic. Syndr., 29, 117–121.
Farrj, R. S., McCully, R. B., Oh, J. K., & Smith, T. F (1997) Mycoplasma associated pericarditis [Review], Mayo Clin. Proceed, 72, 33–36.
Popat, K., Barnardo, D., & Webb-Peploe, M. (1980) Mycoplasma pneumoniae endocarditis, Br. Heart J., 44, 111–112.
Padovan, C. S., Pfister, H. W., Bense, S., Fingerle, V., & Abele-Horn, M. (2001) Detection of Mycoplasma pneumoniae DNA in cerebrospinal fluid of a patient with M. pneumoniae infection-“associated” stroke, Clin. Infect. Dis., 33, E119–21.
Mulder, L. J., & Spierings, E. L. (1987) Stroke in a young adult with Mycoplasma pneumoniae infection complicated by intravascular coagulation, Neurology, 37, 1430–1431.
Fu, M., Wong, K. S., Lam, W. W., & Wong, G. W. (1998) Middle cerebral artery occlusion after recent Mycoplasma pneumoniae infection, J. Neurol Sci., 157, 113–115.
Visudhiphan, P., Chiemchanya, S., & Sirinavin, S. (1992) Internal carotid artery occlusion associated with Mycoplasma pneumoniae infection, Pediatr. Neurol, 8, 237–239.
Parker, P., Puck, J., & Fernandez, F. (1981) Cerebral infarction associated with Mycoplasma pneumoniae, Pediatrics, 67, 373–375.
Higuchi, M. L., Sambiase, N., Palomino, S., Gutierrez, P., Demarchi, L. M., Aiello, V D., & Ramires, J. A. (2001) Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Brazilian J. Med. Biol. Res., 33, 1023–1026.
Fong, I. W, Chiu, B., Viira, E., Jang, D., & Mahony, J. B. (1999) De novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model, Infect. Immun., 67, 6048–6055.
Epstein, S. E., Zhu, I, Burnett, M. S., Zhou, Y. F., Vercellotti, G., & Hajjar, D. (2000) Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry, Artherioscler. Thromb. Vasc. Biol, 20, 1417–1420.
Xu, Q., Willeit, J., Marosi, M., Kleindienst, R., Oberhollenzer, R, Kiechl, S., Stulnig, T., Luef, G., & Wick, G. (1993) Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis, Lancet., 341, 255–259.
Xu, Q., Weimam, S., Gupta, R. S., Wolf, H., & Wick, G. (1993) Staining of endothelial cells and macrophages in atherosclerotic lesions with human heat shock protein reactive antisera, Arterioscler. Thromb., 13, 1763–1769.
Schett, G., Xu, Q., Amberger, A., Van der Zee, R., Recheis, H., Willeit, J., & Wick, G. (1995) Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity, J. Clin. Invest, 96, 2569–2577.
Metzlier, B, Kiechl, S, Mayr, M, Willeit, J., Schett, G, Xu, Q., & Wick, G. (1999) Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis, Circulation, 99, 1560–1566.
Zinkernagel, R. M., Cooper, S., Chambers, J., Lazzarini, R. A., Hengartner, H., & Arnheiter, H. (1990) Virus induced autoantibody response to a transgenic viral antigen, Nature, 345, 68–71.
Anderson, J. L., Carlquist, J. F., Muhlestein, J. B., Home, B., & Elmer, S. P. (1998) Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction, J.Am. Coll. Cardiol., 32, 35–41.
Auer, J., Berent, R., Weber, T., & Eber, B. (2002) Interleukin-1 receptor antagonistgene polymorphism, infectious burden, and coronary artery disease, Clin. Infec. Dis., 34, 1536–1537.
Ridker, P. M, Hennekens, C. H., Buring, J. E., Kundsin, U. & Shih, J. (1999) Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus and cytomegalovirus and the risk for cardiovascular disease in women, Ann. Intern. Med., 131, 573–577.
Roivainen, M., Viik-Kajander, M., Palosuo, T., Toivainen, M., Leinonen, M., Saikku, P., Tenkanen, L,, Manninen, V, Hovi, T., & Manttari, M. (2000) Infections, inflammation, and risk of coronary heart disease, Circulation, 101, 252–257.
Zhu, J., Nieto, I, Horne, B., Anderson, J. L., Muhlestein, J. B., & Epstein, S. E. (2001) Prospective study of pathogen burden and risk of myocardial infarction or death, Circulation, 103, 45–51.
Rupprecht, H. J., Blankenberg, S., Bickel, C., Rippin, G., Hafner, G., Prellwitz, W., Schlumberger, W., & Meyer, J. (2001) Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease, Circulation, 104, 25–31.
Espinola-Klein, C., Rupprecht, H. J., Blankenberg, S., Bickel, C., Kopp, H., Rippin, G., Victor, A., Hafner, G., Schlumberger, W., & Meyer, J. (2002) Impact of infectious burden on extent and long term prognosis of atherosclerosis, Circulation, 105, 15–21.
Chiu, B., Viira, E., Tucker, W., & Fong, I. W. (1997) Chlamydia pneumonia, cytomegalovirus and herpessimplex virus in atherosclerosis of the carotid artery, Circulation, 96, 2144–2148.
Qavi, H. B., Melnick, J. L., Adam, E., & Debakey, M. E. (2000) Frequency of coexistence of cytomegalovirus and Chlamydia pneumoniae in atherosclerotic plaques, Central Eur. J. Public Health, 8, 71–73.
Chiu, B. (1999) Multiple infections in carotid atherosclerotic plaques, Am. Heart J., 128, S534–S536.
Haraszthy, V I., Zambon, J. J., Trevisan, M., Zeid, M., & Genco, R. J. (2000) Identification of periodontal pathogens in atheromatous plaques, J. Periodontal, 71, 1554–1560.
Haraszthy, V. I., Jordan, S. F., Zambon, J. J., Zafiropoulos, G. G., Mastragelopoulos, N., & Genco, R. J. (2001) Periodontal pathogens in atheromas from a German population, Ann. Periodontal, 6, 64 [Abstract].
Wanishsawad, C., Zhou, Y. F, & Epstein, S. E. (2000) Chlamydia pneumoniae-induced transactivation of the major immediate early promoter of cytomegalovirus: potential synergy of infectious agents in the pathogenesis of atherosclerosis, J. Infect. Dis., 181, 787–790.
Burnett, M. S., Gaydos, C. A., Madico, G. E., Glad, S. M., Paigen, B., Quinn, T. C., & Epstein, S. E. (2001) Atherosclerosis in APOE knockout mice infected with multiple pathogens, J. Infect. Dis., 183, 226–231.
Hirose, H., & Kugimiya, T. (2000) Abdominal aortic aneurysm infected with Helicobacter pylori: a case report, Angiology, 51, 867–871.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Kluwer Academic Publishers
About this chapter
Cite this chapter
(2003). Miscellaneous Infections and Atherosclerosis: Cardiovascular and Cerebrovascular Disease. In: Fong, I.W. (eds) Infections and the Cardiovascular System: New Perspectives. Emerging Infectious Diseases of the 21st Century, vol 1. Springer, Boston, MA. https://doi.org/10.1007/0-306-47926-5_8
Download citation
DOI: https://doi.org/10.1007/0-306-47926-5_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47404-0
Online ISBN: 978-0-306-47926-7
eBook Packages: Springer Book Archive